7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5 Remdesivir Intermediate COVID-19
Umkhiqizi Wokuhlinzeka Ngempahla Yezohwebo i-Remdesivir kanye Nezixhumanisi Ezihlobene Nekhwalithi Ephezulu
I-Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
I-Trimethylsilyl Cyanide CAS 7677-24-9
I-4-Nitrophenol CAS 100-02-7
2-Ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
I-Remdesivir Metabolite (GS-441524) CAS 1191237-69-0
I-Remdesivir N-2 I-CAS Emaphakathi 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5
I-Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Igama Lekhemikhali | 7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine |
Omqondofana | 4-Amino-7-bromopyrrolo[2,1-f][1,2,4]triazine;I-Remdesivir Ukungcola 2 |
Inombolo ye-CAS | 937046-98-5 |
Inombolo yeCAT | I-RF-PI305 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifika Emakhulwini Amakhilogremu |
I-Molecular Formula | I-C6H5BrN4 |
Isisindo samangqamuzana | 213.04 |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Impushana Ephuzi Ekhanyayo |
I-Infrared Spectrum | Ivumelana Nesakhiwo |
I-NMR | Ivumelana Nesakhiwo |
Ubumsulwa | ≥97.0% |
Ukulahlekelwa Ekumisweni | ≤1.0 |
Ukungcola Okukodwa | ≤1.0% |
Izinsimbi Ezisindayo | ≤20ppm |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-Intermediate ye-Remdesivir (CAS 1809249-37-3) |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, isigubhu seCardboard, 25kg/Drum, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.
I-7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine (CAS 937046-98-5) iyi-Intermediate of Remdesivir (CAS 1809249-37-3).I-Remdesivir iyisidakamizwa esilwa namagciwane esisebenza ngokumelene ne-acute acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2).I-Remdesivir (eyaziwa nangokuthi i-Veklury noma i-GS-5734) iyi-SARS-CoV-2 nucleotide analog RNA polymerase inhibitor ekhonjiswe abantu abadala kanye neziguli zezingane (ezineminyaka engu-12 ubudala nangaphezulu futhi ezinesisindo okungenani esingama-40 kg) ukuze zelashwe isifo se-coronavirus 2019. (COVID-19) idinga ukulaliswa esibhedlela.I-Remdesivir kufanele inikezwe esibhedlela kuphela noma endaweni yokunakekelwa kwezempilo ekwazi ukunikeza ukunakekelwa okuphuthumayo okufana nokunakekelwa kwesibhedlela esilalisiwe.I-Remdesivir ekuqaleni yasungulwa njenge-anti-viral emelene negciwane le-Ebola, kodwa kusukela lapho ikhonjiswe ukuthi inciphisa inani lamagciwane e-RNA ahlanganisa i-respiratory syncytial virus (RSV) kanye nama-β-coronaviruses afana ne-SARS-CoV, MERS-CoV, kanye i-ejenti eyimbangela ye-COVID-19, SARS-CoV-2.